Literature DB >> 12022427

Respiratory syncytial virus (RSV) outbreak in the NICU: description of eight cases.

Ramzi A Kilani1.   

Abstract

Respiratory syncytial virus (RSV) has been recognized as a major nosocomial hazard on pediatric wards. Because of maternally acquired antibodies, symptomatic RSV infection is rare in term neonates. During an outbreak of RSV in our neonatal ICU, 12 infants (gestational age = 34 +/- 5 weeks) remained RSV negative. In contrast, eight preterm infants (gestational age = 28 +/- 2 weeks) became RSV positive. Four infants became very sick with RSV and required mechanical ventilation and support. Acute respiratory distress syndrome (ARDS) developed in two of them resulting in death of one of them. Control measures were effective in controlling the outbreak. We conclude that during an RSV outbreak in the neonatal ICU, the attack rate is higher in preterm infants born at lower gestational age resulting in significant mortality and morbidity.

Entities:  

Mesh:

Year:  2002        PMID: 12022427     DOI: 10.1093/tropej/48.2.118

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  10 in total

1.  Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database.

Authors:  Arne Simon; Roland A Ammann; Anja Wilkesmann; Anna M Eis-Hübinger; Oliver Schildgen; Edda Weimann; Hans U Peltner; Peter Seiffert; Angela Süss-Grafeo; Jessie R Groothuis; Johannes Liese; Ralf Pallacks; Andreas Müller
Journal:  Eur J Pediatr       Date:  2007-02-16       Impact factor: 3.183

Review 2.  Risk of nosocomial respiratory syncytial virus infection and effectiveness of control measures to prevent transmission events: a systematic review.

Authors:  Clare E French; Bruce C McKenzie; Caroline Coope; Subhadra Rajanaidu; Karthik Paranthaman; Richard Pebody; Jonathan S Nguyen-Van-Tam; Julian P T Higgins; Charles R Beck
Journal:  Influenza Other Respir Viruses       Date:  2016-03-24       Impact factor: 4.380

3.  Human metapneumovirus in the preterm neonate: current perspectives.

Authors:  Nathalie L Maitre; John V Williams
Journal:  Res Rep Neonatol       Date:  2016-07-28

Review 4.  Characterization of Pathogenic Sepsis Etiologies and Patient Profiles: A Novel Approach to Triage and Treatment.

Authors:  Hallie H Dolin; Thomas J Papadimos; Xiaohuan Chen; Zhixing K Pan
Journal:  Microbiol Insights       Date:  2019-01-27

Review 5.  Hospital-acquired viral pathogens in the neonatal intensive care unit.

Authors:  Shari E Gelber; Adam J Ratner
Journal:  Semin Perinatol       Date:  2002-10       Impact factor: 3.300

6.  Respiratory syncytial virus outbreak defined by rapid screening in a neonatal intensive care unit.

Authors:  E A Dizdar; C Aydemir; O Erdeve; F N Sari; S Oguz; N Uras; U Dilmen
Journal:  J Hosp Infect       Date:  2010-03-17       Impact factor: 3.926

7.  An outbreak of RSV infections in a neonatology clinic during the RSV-season.

Authors:  Liliya Vakrilova; Stanislava Hitrova Nikolova; Sergei Slavov; Petya Radulova; Boryana Slancheva
Journal:  BMC Pediatr       Date:  2021-12-11       Impact factor: 2.125

8.  Respiratory syncytial virus as a cause of pulmonary hemorrhage in a low birth weight infant - strategies for protection and prevention: a case report.

Authors:  Shetal Shah; Martha Caprio
Journal:  Cases J       Date:  2009-06-09

9.  Respiratory syncytial virus outbreak in neonatal intensive care unit: Impact of infection control measures plus palivizumab use.

Authors:  Camila de A Silva; Lívio Dias; Sandra R Baltieri; Tatiane T Rodrigues; Neusa Brandolise Takagi; Rosana Richtmann
Journal:  Antimicrob Resist Infect Control       Date:  2012-05-02       Impact factor: 4.887

10.  Incidence of respiratory viral infection in infants with respiratory symptoms evaluated for late-onset sepsis.

Authors:  J B Cerone; R P Santos; D Tristram; D M Lamson; K A Stellrecht; K St George; M J Horgan; A Rios
Journal:  J Perinatol       Date:  2017-05-18       Impact factor: 2.521

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.